A5067602648- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Inflammatory Bowel Disease
- Eosinophilic Disorders and Syndromes
- Eosinophilic Esophagitis
- Gastroesophageal reflux and treatments
- Diagnosis and treatment of tuberculosis
- COVID-19 and healthcare impacts
- Autoimmune and Inflammatory Disorders
- Amoebic Infections and Treatments
- Esophageal and GI Pathology
- Hidradenitis Suppurativa and Treatments
- Biosimilars and Bioanalytical Methods
- Potassium and Related Disorders
- SARS-CoV-2 and COVID-19 Research
- Dermatologic Treatments and Research
- Liver Disease Diagnosis and Treatment
- Skin Diseases and Diabetes
- Intestinal Malrotation and Obstruction Disorders
- Moyamoya disease diagnosis and treatment
- Folate and B Vitamins Research
- Syphilis Diagnosis and Treatment
- Rheumatoid Arthritis Research and Therapies
- COVID-19 diagnosis using AI
- Biliary and Gastrointestinal Fistulas
Hospital Universitario Miguel Servet
2018-2025
Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have occurred due to their active ingredients, formulations and doses.
Abstract This study compared short-term effectiveness of proton pump inhibitors (PPI), swallowed topical corticosteroids (STC), and dietary therapies in reversing clinical histological features pediatric patients with eosinophilic esophagitits (EoE). Determinants for treatment choice PPI therapy were also assessed. A cross-sectional analysis under 18 years old recruited onto the multicenter EoE CONNECT registry was performed. Clinico-histological response defined as symptomatic improvement...
Eosinophilic esophagitis (EoE) predominantly affects males across all ages; however, little is known about sex differences for other aspects of EoE.
apart from the known effects of vitamin D on phospho-calcium homeostasis, in recent years there is great interest its extrabone effects.to know concentration 25-hydroxyvitamin (25[OH] D) newly diagnosed patients cancer and to verify if are differences between different types cancer.cross-sectional study a cohort who were referred Endocrinology consultation for nutritional pre-surgery evaluation. One hundred thirty-nine medical histories reviewed. The socio-demographic biometric data 25(OH)...
Background and Aims: Patients undergoing upper endoscopy have often used proton pump inhibitors (PPI) and/or antibiotics (ABx) recently. Both drugs been associated with a poorer yield of the Helicobacter pylori (H. pylori) diagnostic tests. The aim was to assess accuracy polymerase chain reaction test (qPCR), histological exam (HE) ultra-fast urease (UFUT) for H. detection in patients that recently PPI or ABx.
 Methods: Prospective study recruiting 206 who underwent gastric biopsies....
We present the case of a 38-year-old man with no previous medical history who went to emergency department due abdominal pain and diarrheal stools blood 24 hours evolution. The patient reports consumption anti-inflammatories days back pain.
The long-term benefit of VDZ in IBD patients clinical practice is almost unknown. aims this study were (i) to assess the overall durability response who initially responded induction doses; (ii) identify predictive factors for loosing treatment; and (iii) safety practice. [Crohn’s disease (CD) ulcerative colitis (UC)] that had received at least three doses with ENEIDA registry, a large prospectively maintained Spanish database promoted by GETECCU, included. Patients inactive initiation...
The aims of this study were (1) to assess the effectiveness VDZ in IBD patients and (2) identify factors associated with response treatment. [Crohn’s disease (CD) ulcerative colitis (UC)] that had received at least 3-induction doses ENEIDA registry—a large prospectively maintained Spanish database promoted by Working Group Crohn’s Colitis (GETECCU) included. Patients treated due active [Partial Mayo Score (PMS) ≥2 or Harvey-Bradshaw (HBI) >4] Short-term was evaluated week 14. Clinical...
Abstract Background Three anti-TNFs (one intravenous and two subcutaneous) are licensed for the treatment of ulcerative colitis (UC). However, it is not known if efficacy a second anti-TNF changes on whether or subcutaneous; this could justify indication biological agents with different mechanism action in line. The aim study was to compare subcutaneous UC. Methods Patients from prospectively maintained ENEIDA registry treated consecutively anti-TNF, who were naïve agents, identified....